Invesco Ltd. Pfizer Inc Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Invesco Ltd. holds 30,296,337 shares of PFE stock, worth $711 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

30,296,337

Previous 29,458,139 2.85%

Holding current value

$711 Million

Previous $782 Million 1.77%

% of portfolio

0.15%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$25.01 - $27.13 $21 Million - $22.7 Million	838,198 Added 2.85%	30,296,337 $768 Million
Q4 2024 Feb 13, 2025	BUY	$24.8 - $30.19 $64 Million - $77.9 Million	2,579,455 Added 9.6%	29,458,139 $782 Million
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $2.92 Million - $3.3 Million	105,267 Added 0.39%	26,878,684 $778 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $64.5 Million - $75.5 Million	-2,551,918 Reduced 8.7%	26,773,417 $749 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $135 Million - $155 Million	5,199,072 Added 21.55%	29,325,335 $814 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $1.86 Million - $2.42 Million	71,367 Added 0.3%	24,126,263 $695 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $182 Million - $213 Million	5,678,004 Added 30.9%	24,054,896 $798 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $50 Million - $57.8 Million	1,384,267 Added 8.15%	18,376,892 $674 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $36 Million - $46.9 Million	914,358 Added 5.69%	16,992,625 $693 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $21.8 Million - $28.5 Million	522,447 Added 3.36%	16,078,267 $824 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $109 Million - $133 Million	2,484,509 Added 19.01%	15,555,820 $681 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $167 Million - $197 Million	-3,579,592 Reduced 21.5%	13,071,311 $685 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $150 Million - $186 Million	-3,285,874 Reduced 16.48%	16,650,903 $862 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $20.6 Million - $30.6 Million	-498,860 Reduced 2.44%	19,936,777 $1.18 Billion
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $20.9 Million - $26.8 Million	-532,523 Reduced 2.54%	20,435,637 $879 Million
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $111 Million - $125 Million	3,077,632 Added 17.2%	20,968,160 $821 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $38.1 Million - $43 Million	1,138,391 Added 6.8%	17,890,528 $648 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $58.6 Million - $74.5 Million	-1,749,945 Reduced 9.46%	16,752,137 $617 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $32.4 Million - $38 Million	-1,021,237 Reduced 5.23%	18,502,082 $679 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $35.4 Million - $43 Million	-1,175,589 Reduced 5.68%	19,523,319 $638 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $72.3 Million - $103 Million	2,673,098 Added 14.83%	20,698,908 $676 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $73.4 Million - $83.3 Million	-2,228,597 Reduced 11.0%	18,025,810 $706 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $28.1 Million - $36.4 Million	-864,199 Reduced 4.09%	20,254,407 $728 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $99.6 Million - $112 Million	2,693,349 Added 14.62%	21,118,606 $915 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $233 Million - $256 Million	-6,215,063 Reduced 25.22%	18,425,257 $783 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $948 Million - $1.08 Billion	24,640,320 New	24,640,320 $1.08 Billion

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $132B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account